CLINICAL_TRIALS
trial_result
· 2021-06-02
Clinical Trial Update: A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension [Phase 2]
Summary
Phase 2 trial evaluating the effects of LCI699 on cortisol in participants with hypertension has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2021-06-02